Thomas Civik

Chief Commercial Officer, Foundation Medicine, Inc.

Companies

Pyxis Oncology, Inc.Chair Sep 8, 2026 to now¹
Pyxis Oncology, Inc.Chief executive officer Feb 5, 2026 to now²
Pyxis Oncology, Inc.Board member Oct 7, 2021 to now³
Repare Therapeutics Inc.Board member Sep 9, 2021 to now⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Pyxis Oncology, Inc. PYXS221,886 shares⁵$399.4K at $1.80Mar 28, 2023
Repare Therapeutics Inc.0 shares⁶Jan 28, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 28, 2026Returned to company 7,500 shares of Repare Therapeutics Inc.⁶
Mar 24, 2023Granted 139,355 shares of Pyxis Oncology, Inc.⁵
Mar 31, 2022Granted 66,831 shares of Pyxis Oncology, Inc.⁷
Nov 18, 2021Bought 15,700 shares at $12.74 of Pyxis Oncology, Inc.⁸
Nov 16, 2021Bought 7,500 shares at $28.08 of Repare Therapeutics Inc.⁹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARPyxis Oncology, Inc., Chair
2
SEC EDGARPyxis Oncology, Inc., Chief executive officer
3
SEC EDGARPyxis Oncology, Inc., Board member
4
SEC EDGARRepare Therapeutics Inc., Board member
5
SEC EDGARPyxis Oncology, Inc. shares after the filing of Mar 28, 2023
6
SEC EDGARRepare Therapeutics Inc. shares after the filing of Jan 28, 2026
7
SEC EDGARForm 4 filed Apr 4, 2022
8
SEC EDGARForm 4 filed Nov 19, 2021
9
SEC EDGARForm 4 filed Nov 18, 2021